Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Leon L, Rodriguez-Rodriguez L, Freites D, Arietti L, Morado I, Vadillo C, Lamas JR, Fernandez B, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):173. Epub 2018 Feb 6. No abstract available.

2.

Laparoscopic diagnosis and repair of Spigelian hernia: A case report and literature review.

Mederos R, Lamas JR, Alvarado J, Matos M, Padron I, Ramos A.

Int J Surg Case Rep. 2017;31:184-187. doi: 10.1016/j.ijscr.2017.01.043. Epub 2017 Jan 20.

3.

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Leon L, Rodriguez-Rodriguez L, Freites D, Arietti L, Morado I, Vadillo C, Lamas JR, Fernandez B, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):165-170. Epub 2017 Jan 23.

PMID:
28134073
4.

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

Leon L, Rodriguez-Rodriguez L, Rosales Z, Gomez A, Lamas JR, Pato E, Jover JA, Abasolo L.

Scand J Rheumatol. 2016 Nov;45(6):456-460. Epub 2016 Apr 26.

PMID:
27115843
5.

Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.

Rodriguez-Rodriguez L, Leon L, Ivorra-Cortes J, Gómez A, Lamas JR, Pato E, Jover JÁ, Abásolo L.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1026-1032. Epub 2016 Oct 7.

PMID:
27749239
6.

Dose down-titration of biological DMARDs in patients with rheumatoid arthritis over time and in daily clinical practice.

Rodriguez-Rodriguez L, Leon L, Lamas JR, Gomez A, Vadillo C, Blanco M, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):872-879. Epub 2016 May 19.

PMID:
27214094
7.

Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients.

Tornero-Esteban P, Peralta-Sastre A, Herranz E, Rodríguez-Rodríguez L, Mucientes A, Abásolo L, Marco F, Fernández-Gutiérrez B, Lamas JR.

PLoS One. 2015 Sep 9;10(9):e0137170. doi: 10.1371/journal.pone.0137170. eCollection 2015.

8.

Signature of microRNA expression during osteogenic differentiation of bone marrow MSCs reveals a putative role of miR-335-5p in osteoarthritis.

Tornero-Esteban P, Rodríguez-Rodríguez L, Abásolo L, Tomé M, López-Romero P, Herranz E, González MA, Marco F, Moro E, Fernández-Gutiérrez B, Lamas JR.

BMC Musculoskelet Disord. 2015 Aug 5;16:182. doi: 10.1186/s12891-015-0652-9.

9.

Selected reaction monitoring assays in mesenchymal stem cells from osteoarthritis patients.

Camafeita E, Lamas JR, Calvo E, Tornero-Esteban P, López JA, Fernández-Gutiérrez B.

Clin Proteomics. 2014 Sep 1;11(1):33. doi: 10.1186/1559-0275-11-33. eCollection 2014.

10.

Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy.

Leon L, Abasolo L, Carmona L, Rodriguez-Rodriguez L, Lamas JR, Hernandez-Garcia C, Jover JA; emAR Study Group.

J Rheumatol. 2013 Nov;40(11):1850-5. doi: 10.3899/jrheum.130118. Epub 2013 Sep 15.

PMID:
24037551
11.

Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.

Garcia-Montojo M, Varade J, Villafuertes E, de La Hera B, Hoyas-Fernandez J, Domínguez-Mozo MI, Rodriguez-Rodriguez L, Tornero-Esteban P, Arias-Leal A, León L, Lamas JR, Alvarez-Lafuente R, Urcelay E, Fernandez-Gutierrez B.

Scand J Rheumatol. 2013;42(6):498-504. doi: 10.3109/03009742.2013.779021. Epub 2013 May 11.

PMID:
23662747
12.

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis.

de la Hera B, Varadé J, García-Montojo M, Lamas JR, de la Encarnación A, Arroyo R, Fernández-Gutiérrez B, Alvarez-Lafuente R, Urcelay E.

PLoS One. 2013 Apr 25;8(4):e62090. doi: 10.1371/journal.pone.0062090. Print 2013.

13.

Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.

Lamas JR, Rodríguez-Rodríguez L, Tornero-Esteban P, Villafuertes E, Hoyas J, Abasolo L, Varadé J, Alvarez-Lafuente R, Urcelay E, Fernández-Gutiérrez B.

Cytokine. 2013 Mar;61(3):720-3. doi: 10.1016/j.cyto.2012.12.025. Epub 2013 Jan 29.

PMID:
23375120
14.

NPSR1 gene is associated with reduced risk of rheumatoid arthritis.

Robledo G, González-Gay MA, Fernández-Gutiérrez B, Lamas JR, Balsa A, Pascual-Salcedo D, Castañeda S, Blanco R, González-Alvaro I, García A, Raya E, Gómez-Vaquero C, Delgado M, Martín J.

J Rheumatol. 2012 Jun;39(6):1166-70. doi: 10.3899/jrheum.111205. Epub 2012 May 1.

PMID:
22548958
15.

Combined influence of genetic and environmental factors in age of rheumatoid arthritis onset.

Rodríguez-Rodríguez L, Lamas JR, Varadé J, Tornero-Esteban P, Abasolo L, de la Concha EG, Jover JA, Urcelay E, Fernández-Gutiérrez B.

Rheumatol Int. 2012 Oct;32(10):3097-102. Epub 2011 Sep 16.

PMID:
21922340
16.

Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.

Rodríguez-Rodríguez L, Lamas JR, Varadé J, López-Romero P, Tornero-Esteban P, Abasolo L, de la Concha EG, Jover JA, Urcelay E, Fernández-Gutiérrez B.

Rheumatol Int. 2011 Mar;31(3):409-13. doi: 10.1007/s00296-010-1593-0. Epub 2010 Jul 27.

PMID:
20661738
17.

Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis.

Perdigones N, Martín E, Robledo G, Lamas JR, Taxonera C, Díaz-Rubio M, de la Concha EG, López-Nevot MA, García A, Gómez-García M, Fernández-Gutiérrez B, Martín J, Urcelay E.

Hum Immunol. 2010 Aug;71(8):826-8. doi: 10.1016/j.humimm.2010.05.010. Epub 2010 May 16.

PMID:
20561984
18.

Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis.

Lamas JR, Rodríguez-Rodríguez L, Varadé J, López-Romero P, Tornero-Esteban P, Abasolo L, Urcelay E, Fernández-Gutiérrez B.

J Rheumatol. 2010 Aug 1;37(8):1579-81. doi: 10.3899/jrheum.091455. Epub 2010 Jun 15.

PMID:
20551110
19.

Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritis.

Lamas JR, Rodríguez-Rodríguez L, Vigo AG, Alvarez-Lafuente R, López-Romero P, Marco F, Camafeita E, Dopazo A, Callejas S, Villafuertes E, Hoyas JA, Tornero-Esteban MP, Urcelay E, Fernández-Gutiérrez B.

Ann Rheum Dis. 2010 Oct;69(10):1880-5. doi: 10.1136/ard.2009.122564. Epub 2010 May 24.

PMID:
20498197
20.

Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis.

Robledo G, Rueda B, Gonzalez-Gay MA, Fernández B, Lamas JR, Balsa A, Pascual-Salcedo D, García A, Raya E, Martín J.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):25-9.

PMID:
20346234
21.

Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis.

Perdigones N, Vigo AG, Lamas JR, Martínez A, Balsa A, Pascual-Salcedo D, de la Concha EG, Fernández-Gutiérrez B, Urcelay E.

Arthritis Rheum. 2010 Mar;62(3):705-10. doi: 10.1002/art.27292.

22.

Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.

Suarez-Gestal M, Calaza M, Dieguez-Gonzalez R, Perez-Pampin E, Pablos JL, Navarro F, Narvaez J, Marenco JL, Herrero-Beaumont G, Fernandez-Gutierrez B, Lamas JR, de la Serna AR, Ortiz AM, Carreño L, Cañete JD, Caliz R, Blanco FJ, Balsa A, Gomez-Reino JJ, Gonzalez A.

Arthritis Rheum. 2009 Sep;60(9):2558-64. doi: 10.1002/art.24748.

23.

NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis.

Varadé J, Lamas JR, Fernández-Arquero M, Jover JA, de la Concha EG, Martínez A, Fernández-Gutierrez B, Urcelay E.

Nitric Oxide. 2009 Nov-Dec;21(3-4):171-4. doi: 10.1016/j.niox.2009.07.005. Epub 2009 Jul 25.

PMID:
19635578
24.

Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.

Dieguez-Gonzalez R, Akar S, Calaza M, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Lamas JR, de la Serna AR, Caliz R, Blanco FJ, Pascual-Salcedo D, Velloso ML, Perez-Pampin E, Pablos JL, Navarro F, Narvaez J, Lopez-Longo FJ, Herrero-Beaumont G, Gomez-Reino JJ, Gonzalez A.

J Rheumatol. 2009 Aug;36(8):1590-5. doi: 10.3899/jrheum.090022. Epub 2009 Jun 30.

PMID:
19567623
25.

Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis.

Varadé J, Loza-Santamaría E, Fernández-Arquero M, Lamas JR, de Los Angeles Figueredo M, Jover JA, de la Concha EG, Rodríguez L, Urcelay E, Fernández-Gutiérrez B, Martínez-Doncel A.

J Rheumatol. 2009 May;36(5):1085-6. doi: 10.3899/jrheum.080735. No abstract available.

PMID:
19435975
26.

Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis.

Palomino-Morales R, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Ortego-Centeno N, Miranda-Filloy JA, Lamas JR, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2009 May;36(5):1021-5. doi: 10.3899/jrheum.081060. Epub 2009 Mar 30.

PMID:
19332627
27.

6q23 polymorphisms in rheumatoid arthritis Spanish patients.

Perdigones N, Lamas JR, Vigo AG, de la Concha EG, Jover JA, Urcelay E, Gutiérrez BF, Martínez A.

Rheumatology (Oxford). 2009 Jun;48(6):618-21. doi: 10.1093/rheumatology/kep053. Epub 2009 Mar 25.

PMID:
19321514
28.

Chromosomal region 16p13: further evidence of increased predisposition to immune diseases.

Martínez A, Perdigones N, Cénit MC, Espino L, Varadé J, Lamas JR, Santiago JL, Fernández-Arquero M, de la Calle H, Arroyo R, de la Concha EG, Fernández-Gutiérrez B, Urcelay E.

Ann Rheum Dis. 2010 Jan;69(1):309-11. doi: 10.1136/ard.2008.098376. Erratum in: Ann Rheum Dis. 2011 Jan;70(1):240.

PMID:
19221398
29.

Proteomics: New insights into rheumatic diseases.

Camafeita E, Lamas JR, Calvo E, López JA, Fernández-Gutiérrez B.

Proteomics Clin Appl. 2009 Feb;3(2):226-41. doi: 10.1002/prca.200800146.

PMID:
26238621
30.

GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis.

Martínez A, Varadé J, Lamas JR, Fernández-Arquero M, Jover JA, de la Concha EG, Fernández-Gutiérrez B, Urcelay E.

Ann Rheum Dis. 2008 Sep;67(9):1352-3. doi: 10.1136/ard.2007.085050. No abstract available. Erratum in: Ann Rheum Dis. 2009 Jun;68(6):1080.

PMID:
18697781
31.

Investigation of CD69 as a new candidate gene for rheumatoid arthritis.

Rueda B, Fernandez-Gutierrez B, Balsa A, Pacual-Salcedo D, Lamas JR, Raya E, Gonzalez-Gay MA, Martin J.

Tissue Antigens. 2008 Sep;72(3):206-10. doi: 10.1111/j.1399-0039.2008.01094.x. Epub 2008 May 29.

PMID:
18627570
32.

Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases.

Martínez A, Santiago JL, Varadé J, Márquez A, Lamas JR, Mendoza JL, de la Calle H, Díaz-Rubio M, de la Concha EG, Fernández-Gutiérrez B, Urcelay E.

BMC Genomics. 2008 Jul 14;9:329. doi: 10.1186/1471-2164-9-329.

33.

Association of the IFIH1-GCA-KCNH7 chromosomal region with rheumatoid arthritis.

Martínez A, Varadé J, Lamas JR, Fernández-Arquero M, Jover JA, de la Concha EG, Fernández-Gutiérrez B, Urcelay E.

Ann Rheum Dis. 2008 Jan;67(1):137-8. No abstract available.

PMID:
18077546
34.

Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction.

Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, Jover JA, Rollin R, Loza E, Clemente D, Lamas JR.

Ann Rheum Dis. 2005 Sep;64(9):1357-9.

35.

PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population.

Martinez A, Valdivia A, Pascual-Salcedo D, Lamas JR, Fernández-Arquero M, Balsa A, Fernández-Gutiérrez B, de la Concha EG, Urcelay E.

Rheumatology (Oxford). 2005 Oct;44(10):1263-6. Epub 2005 Jul 5.

PMID:
15998632
36.

Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction.

Alvarez-Lafuente R, Fernández-Gutiérrez B, Jover JA, Júdez E, Loza E, Clemente D, García-Asenjo JA, Lamas JR.

Ann Rheum Dis. 2005 May;64(5):780-2.

37.

Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity.

Campillos M, Lamas JR, García MA, Bullido MJ, Valdivieso F, Vázquez J.

Nucleic Acids Res. 2003 Jun 15;31(12):3063-70.

38.

The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions.

Sesma L, Montserrat V, Lamas JR, Marina A, Vázquez J, López de Castro JA.

J Biol Chem. 2002 May 10;277(19):16744-9. Epub 2002 Mar 1.

39.
40.
41.

Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.

Poenaru S, Lamas JR, Folkers G, López de Castro JA, Seebach D, Rognan D.

J Med Chem. 1999 Jul 1;42(13):2318-31.

PMID:
10395472
42.

Structure-based design of nonnatural ligands for the HLA-B27 protein.

Dédier S, Krebs S, Lamas JR, Poenaru S, Folkers G, López de Castro JA, Seebach D, Rognan D.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):645-57.

PMID:
10071790
43.

Substituting nonpeptidic spacers for the T cell receptor-binding part of class I major histocompatibility complex-binding peptides.

Krebs S, Lamas JR, Poenaru S, Folkers G, de Castro JA, Seebach D, Rognan D.

J Biol Chem. 1998 Jul 24;273(30):19072-9.

44.

Effects of a negative visual hypnotic hallucination on ERPs and reaction times.

Lamas JR, Valle-Inclán F.

Int J Psychophysiol. 1998 Jun;29(1):77-82.

PMID:
9641250
45.

Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27.

Lamas JR, Brooks JM, Galocha B, Rickinson AB, López de Castro JA.

Int Immunol. 1998 Mar;10(3):259-66.

PMID:
9576613
46.

An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity.

García F, Rognan D, Lamas JR, Marina A, López de Castro JA.

Tissue Antigens. 1998 Jan;51(1):1-9.

PMID:
9459498
47.

Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.

Rognan D, Krebs S, Kuonen O, Lamas JR, López de Castro JA, Folkers G.

J Comput Aided Mol Des. 1997 Sep;11(5):463-78.

PMID:
9385550
48.

HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket.

García F, Galocha B, Villadangos JA, Lamas JR, Albar JP, Marina A, Lópaz de Castro JA.

Tissue Antigens. 1997 Jun;49(6):580-7.

PMID:
9234479
49.

Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism.

Galocha B, Lamas JR, Villadangos JA, Albar JP, López de Castro JA.

Tissue Antigens. 1996 Nov;48(5):509-18.

PMID:
8988533
50.

Spanish norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.

Lamas JR, del Valle-Inclan F, Blanco MJ, Diaz AA.

Int J Clin Exp Hypn. 1989 Jul;37(3):264-73.

PMID:
2753576

Supplemental Content

Loading ...
Support Center